Marginal zone lymphoma – Basic Information

Go back

Marginal zone lymphoma is a rare, slow-growing type of blood cancer that develops when certain white blood cells change and multiply uncontrollably. This disease typically affects older adults and can arise in various parts of the body, from the stomach lining to the lymph nodes and spleen. While the diagnosis can be overwhelming, many people with this condition live for years with proper care, and some forms can even be treated successfully by addressing underlying infections.

Understanding How Common Marginal Zone Lymphoma Is

Marginal zone lymphoma is not a disease that affects large numbers of people. Among all types of non-Hodgkin lymphoma (a group of cancers affecting the lymphatic system), marginal zone lymphoma accounts for approximately five to seventeen percent of cases. When looking at the three different subtypes, the distribution varies quite a bit. The most common form, called extranodal marginal zone lymphoma or MALT lymphoma, makes up about 50 to 70 percent of all marginal zone lymphoma cases. The splenic form accounts for roughly 20 percent, while the nodal type represents about 10 percent of these cancers.[5]

This type of lymphoma tends to appear in people who are older rather than younger. The average age when someone receives a diagnosis is around 60 years old, though it can develop at other ages as well.[4] When researchers look at whether the disease affects one gender more than the other, the picture becomes slightly complicated. Some sources indicate that marginal zone lymphoma is slightly more common in women than in men.[4] However, other medical centers report that it tends to be more common in men than in women.[2] These differences might reflect variations in the specific subtypes being studied or differences in the populations examined.

The disease develops in lymphoid tissue, which is tissue containing white blood cells called B cells or B lymphocytes. These tissues are found throughout the body as part of the immune system, including in lymph nodes, the spleen, and various mucous membranes lining organs like the stomach, lungs, and eyes. Because lymphoid tissue exists in so many places, marginal zone lymphoma can potentially develop in many different body sites, leading to a wide range of presentations and symptoms depending on where the cancer first appears.[2]

What Causes This Type of Lymphoma

The causes of marginal zone lymphoma are not completely understood, but researchers have identified several important factors that appear to trigger or contribute to the development of this disease. Unlike some cancers that seem to appear randomly, marginal zone lymphoma has strong connections to chronic inflammation caused by infections and autoimmune conditions. This makes it somewhat unique among cancers, as treating the underlying trigger can sometimes lead to the disappearance of the lymphoma itself.[5]

For the most common form of marginal zone lymphoma, which develops in the stomach lining, the main culprit is a bacterial infection with Helicobacter pylori, often called H. pylori. This bacterium causes long-term inflammation of the stomach lining. Over time, the constant irritation and immune system activation can lead normal B cells to transform into cancer cells. The connection is so strong that most people with gastric MALT lymphoma have evidence of H. pylori infection.[2] When doctors treat the infection with antibiotics, the lymphoma often goes away completely, though this can take several months to happen.[7]

Beyond H. pylori, other infections have been linked to different forms of marginal zone lymphoma. Hepatitis C virus has been associated with both splenic marginal zone lymphoma and nodal marginal zone lymphoma.[2] This virus causes chronic liver inflammation, and the ongoing immune system activation appears to increase the risk of developing lymphoma. When marginal zone lymphoma develops in the area around the eye, it has been connected to a different type of bacterial infection, and antibiotic treatment with doxycycline has shown effectiveness in making these lymphomas shrink or disappear.[7]

Autoimmune diseases are conditions where the immune system mistakenly attacks the body’s own tissues, causing chronic inflammation. Several autoimmune conditions have been linked to marginal zone lymphoma. Hashimoto’s disease, which affects the thyroid gland, and Sjögren’s syndrome, which affects glands that produce tears and saliva, are both associated with the development of MALT lymphoma in the affected organs. The constant immune activity in these conditions appears to create an environment where lymphoma can develop.[2]

⚠️ Important
One of the most distinctive features of marginal zone lymphoma is that many cases are directly connected to persistent immune system stimulation from chronic infections or autoimmune diseases. This means that identifying and treating these underlying conditions can sometimes cure the lymphoma without needing traditional cancer treatments like chemotherapy. This makes testing for infections like H. pylori or hepatitis C an essential part of diagnosis and treatment planning.

Who Is at Higher Risk

Understanding risk factors can help people and their doctors stay alert to potential warning signs, though having risk factors does not mean someone will definitely develop marginal zone lymphoma. Family history appears to play a role in risk. People who have close relatives diagnosed with lymphoma face a higher chance of developing marginal zone lymphoma themselves compared to those without such family history.[2] This suggests that genetic factors may influence susceptibility to the disease, though the specific genes involved are still being studied.

Frequent or chronic infections create ongoing inflammation and immune system activation. This constant stimulation of B cells increases the chance that mutations will occur, leading to the transformation of normal cells into cancer cells. This is why infections like H. pylori, hepatitis C, and certain bacterial infections near the eye have been so strongly linked to different forms of marginal zone lymphoma. The longer the infection persists untreated, the greater the cumulative risk appears to be.[2]

People living with autoimmune diseases face elevated risk for several reasons. First, these conditions involve chronic inflammation, which creates an environment conducive to cancer development. Second, many people with autoimmune diseases take medications that suppress the immune system to control their symptoms. While these treatments are necessary and beneficial for managing the primary disease, they can potentially increase cancer risk over time. Conditions specifically linked to marginal zone lymphoma risk include Hashimoto’s disease, which affects the thyroid, and Sjögren’s syndrome, which affects moisture-producing glands throughout the body.[2]

Recognizing the Symptoms

One of the challenging aspects of marginal zone lymphoma is that it grows very slowly and may not cause any noticeable symptoms for quite some time. Some people discover they have this condition only when undergoing tests or examinations for completely unrelated reasons. When symptoms do appear, they can vary significantly depending on which subtype of marginal zone lymphoma someone has and where in the body the cancer is located.[2]

There are some general symptoms that can occur with any type of marginal zone lymphoma. These include fever that occurs without an obvious infection, night sweats that are severe enough to soak through nightclothes and bedding, and unexplained weight loss where someone loses a significant amount of weight without trying.[2] These three symptoms together are sometimes called “B symptoms” by doctors and can indicate that the lymphoma is more active or widespread.

When marginal zone lymphoma develops in the stomach, which is the most common location, symptoms relate to digestive problems. People might experience nausea and vomiting, pain or discomfort in the belly area, and a feeling of fullness or bloating even after eating just a small amount of food. These symptoms occur because the lymphoma cells infiltrate the stomach lining, interfering with its normal function.[2] Unfortunately, these symptoms can easily be mistaken for common digestive problems like ulcers or gastritis, which is why the underlying lymphoma sometimes goes undiagnosed initially.

Non-gastric MALT lymphoma, which develops outside the stomach, produces symptoms based on its location. When it affects the area around the eyes, people might notice changes to the surface of the eye or problems with tear production. Lymphoma in the lungs might cause breathing difficulties or persistent cough. When it develops in the skin, visible lumps or patches might appear.[2] Each location produces its own characteristic set of symptoms.

Nodal marginal zone lymphoma primarily affects the lymph nodes. The main symptom is often painless swelling of lymph nodes, particularly in the neck, armpits, or groin area. These swollen nodes might be discovered by the person themselves or by a doctor during a physical examination. General symptoms like fever, night sweats, and unexplained weight loss can also occur.[2]

Splenic marginal zone lymphoma has its own distinct pattern of symptoms because it primarily affects the spleen, blood, and bone marrow. The most common symptom is fatigue, which happens because the disease can interfere with normal blood cell production. The spleen often becomes enlarged, sometimes growing large enough to be felt in the abdomen or causing discomfort. Night sweats and unexplained weight loss can also occur with this subtype.[2] Some people might notice they bruise more easily or get infections more frequently due to the effects on blood cell counts.

Ways to Prevent Marginal Zone Lymphoma

Unlike some other health conditions where prevention strategies are well-established, preventing marginal zone lymphoma is more challenging because scientists do not yet fully understand all the causes. However, there are some logical steps that might reduce risk, particularly given what is known about the disease’s connection to infections and chronic inflammation.

Treating H. pylori infections promptly and completely is one potentially important preventive measure. Since this bacterial infection is so strongly linked to gastric MALT lymphoma, eliminating the infection before lymphoma develops makes sense as a prevention strategy. People who experience persistent stomach discomfort, heartburn, or other digestive symptoms should see their doctor for evaluation. If H. pylori is detected through breath tests, stool tests, or endoscopy with biopsy, a course of antibiotics combined with medications to reduce stomach acid can usually eliminate the infection.[7] Successfully eradicating the bacteria removes the chronic inflammatory stimulus that can eventually lead to lymphoma.

Managing autoimmune diseases properly under medical supervision might also play a role in prevention. While having an autoimmune condition does increase risk, keeping the disease well-controlled with appropriate treatment might help reduce the chronic inflammation that contributes to lymphoma development. People with conditions like Hashimoto’s disease or Sjögren’s syndrome should maintain regular follow-up with their healthcare providers and take prescribed medications as directed.

Addressing hepatitis C infection is another potential preventive step. With modern antiviral medications, hepatitis C can often be cured completely. Since this viral infection has been associated with both splenic and nodal marginal zone lymphoma, treating it might reduce risk. People who have risk factors for hepatitis C, such as past injection drug use, blood transfusions before screening was implemented, or certain exposures during medical procedures, should discuss testing with their doctor.[2]

Beyond these specific measures, maintaining general immune system health through a balanced diet, regular physical activity, adequate sleep, and stress management makes sense as part of an overall approach to reducing cancer risk. However, it is important to understand that even with these measures, some people will still develop marginal zone lymphoma because genetic factors and other unknown influences also contribute to the disease.

How the Disease Changes Body Function

To understand what happens in marginal zone lymphoma, it helps to know a bit about normal immune system function. The immune system includes organs, glands, tubes, and clusters of cells called lymph nodes that work together to protect the body from germs and other threats. Within this system, specialized areas called marginal zones exist at the edges of normal lymphoid tissue. These marginal zones contain B lymphocytes that act as rapid responders, quickly producing antibodies when they encounter bacteria, viruses, or other foreign substances.[5]

In marginal zone lymphoma, something goes wrong with the B cells in these marginal zones. Changes occur in the genetic material inside the cells, causing them to transform into cancer cells. Unlike normal B cells, which have a limited lifespan and die off after completing their immune functions, these transformed lymphoma cells continue dividing and accumulating. They do not die when they should, and they multiply more than they should, gradually crowding out normal cells.[1]

The cancer cells can remain localized in one area for a long time because marginal zone lymphoma is an indolent or slow-growing cancer. This is different from aggressive lymphomas that spread rapidly throughout the body. The slow growth explains why many people have the disease for months or even years before symptoms become noticeable. Eventually, however, the accumulating cancer cells begin to interfere with the normal function of whatever organ or tissue they are in.[2]

In the stomach, for example, lymphoma cells infiltrating the lining can disrupt normal digestive processes, causing pain, nausea, and other symptoms. When lymphoma develops in the spleen, the organ can become enlarged and less efficient at filtering blood and storing blood cells. This can lead to low blood counts, causing fatigue, increased infection risk, and easy bruising. In lymph nodes, the accumulation of cancer cells causes swelling and can eventually affect the node’s ability to function properly in immune surveillance.[2]

The bone marrow can also become involved in marginal zone lymphoma, particularly in the splenic and nodal forms. When lymphoma cells infiltrate the bone marrow, they can interfere with the production of normal blood cells. This can lead to anemia (low red blood cell count causing fatigue), thrombocytopenia (low platelet count increasing bleeding risk), or leukopenia (low white blood cell count increasing infection risk).

An important aspect of marginal zone lymphoma’s pathophysiology is its responsiveness to antigen stimulation. Because these lymphomas often arise in the context of chronic infection or autoimmune disease, the cancer cells may continue to be driven by the same stimuli that affect normal B cells. This is why eliminating the infectious trigger, such as H. pylori in gastric MALT lymphoma, can sometimes lead to regression of the cancer. When the chronic stimulation is removed, the lymphoma cells may stop proliferating and gradually die off, allowing the tissue to return to normal over time.[10]

⚠️ Important
While marginal zone lymphoma is generally slow-growing, there is a possibility that it can transform into a more aggressive type of lymphoma over time, particularly diffuse large B-cell lymphoma. This transformation occurs in a small percentage of cases but is one reason why ongoing monitoring remains important even when the disease appears stable. Symptoms of transformation include rapidly enlarging lymph nodes, worsening B symptoms, or sudden deterioration in overall health. Any such changes should prompt immediate medical evaluation.

Ongoing Clinical Trials on Marginal zone lymphoma

  • Study of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Italy Portugal
  • Study of Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

    Not recruiting

    1 1 1
    France
  • Study on [68Ga]Ga-PentixaFor and [18F]FDG PET/CT Imaging for Staging Marginal Zone Lymphoma in Patients with Confirmed Diagnosis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Austria France Germany Italy Spain
  • Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark Finland France +10
  • Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium Bulgaria Czechia France Germany +8

References

https://www.mayoclinic.org/diseases-conditions/marginal-zone-lymphoma/symptoms-causes/syc-20586112

https://my.clevelandclinic.org/health/diseases/24915-marginal-zone-lymphoma

https://www.mdanderson.org/cancerwise/4-things-to-know-about-marginal-zone-lymphoma.h00-159620223.html

https://lymphoma.org/understanding-lymphoma/aboutlymphoma/nhl/mzl/

https://en.wikipedia.org/wiki/Marginal_zone_lymphoma

https://lymphoma-action.org.uk/types-lymphoma-non-hodgkin-lymphoma/nodal-marginal-zone-lymphoma

https://www.lymphoma.org/understanding-lymphoma/aboutlymphoma/nhl/mzl/mzltreatment/

https://www.mayoclinic.org/diseases-conditions/marginal-zone-lymphoma/diagnosis-treatment/drc-20586125

https://www.aacr.org/patients-caregivers/progress-against-cancer/a-new-treatment-for-marginal-zone-lymphoma/

https://pubmed.ncbi.nlm.nih.gov/40517548/

FAQ

Can marginal zone lymphoma be cured?

Some types of marginal zone lymphoma can be cured, particularly gastric MALT lymphoma associated with H. pylori infection. When treated with antibiotics to eliminate the bacteria, about 90 percent of these lymphomas go away completely. However, for other subtypes or advanced cases, the disease is typically managed as a chronic condition rather than cured, though many people live for many years with treatment.

How is marginal zone lymphoma diagnosed?

Diagnosis typically begins with a physical examination checking for swollen lymph nodes or an enlarged spleen. Blood tests can reveal lymphoma cells and check for infections like hepatitis C. Imaging tests such as CT scans, MRI, PET scans, or ultrasound show the extent of the disease. The definitive diagnosis comes from a biopsy, where tissue is removed from an affected area and examined under a microscope. For gastric cases, an endoscopy allows doctors to view and biopsy the stomach lining.

What is watchful waiting and when is it used?

Watchful waiting, also called active surveillance, is an approach where doctors monitor the lymphoma closely without immediately starting treatment. This strategy is used when someone has slow-growing marginal zone lymphoma without symptoms or signs of rapid progression. Regular checkups, blood tests, and imaging studies track the disease. Treatment begins only if symptoms develop or the lymphoma starts growing faster. This approach avoids unnecessary treatment side effects while keeping the disease under close observation.

What treatments are available besides antibiotics?

Treatment options beyond antibiotics include radiation therapy, which uses high-energy beams to kill cancer cells; immunotherapy with drugs like rituximab that help the immune system attack cancer cells; chemotherapy, which uses drugs to destroy rapidly dividing cells; targeted therapy, which attacks specific abnormalities in cancer cells; and sometimes surgery to remove affected tissue. For advanced or resistant disease, bone marrow or stem cell transplantation might be considered. The specific approach depends on the lymphoma type, location, stage, and individual patient factors.

Will I need to change my diet if I have marginal zone lymphoma?

While no specific diet can cure marginal zone lymphoma, eating well is important for overall health and supporting your body through treatment. Focus on a balanced diet with plenty of fruits, vegetables, whole grains, lean proteins, and healthy fats. If you have gastric MALT lymphoma, you might need to avoid foods that irritate your stomach during treatment. Some people find that eating smaller, more frequent meals helps if they experience digestive symptoms. Talk with your healthcare team about any dietary concerns, as they may recommend meeting with a nutritionist.

🎯 Key Takeaways

  • Marginal zone lymphoma is unique among cancers because many cases are directly linked to chronic infections or autoimmune diseases that can be treated
  • About 90 percent of gastric MALT lymphomas disappear completely when H. pylori infection is treated with antibiotics, making it one of the few cancers curable with antibiotic therapy
  • This is a slow-growing cancer that usually affects people around age 60, and many people have no symptoms for months or years
  • The disease accounts for 5-17% of all non-Hodgkin lymphomas, with the extranodal or MALT form being the most common subtype
  • Risk factors include having a family history of lymphoma, chronic infections like H. pylori or hepatitis C, and autoimmune diseases like Hashimoto’s disease or Sjögren’s syndrome
  • Watchful waiting is a valid approach for people without symptoms, avoiding treatment side effects while keeping the disease under close observation
  • The disease can develop in unexpected places throughout the body including the stomach, eyes, lungs, skin, thyroid, and salivary glands—anywhere mucous membranes exist
  • While generally indolent, the disease can sometimes transform into more aggressive lymphoma, making ongoing monitoring important even during stable periods